Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AnaptysBio, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ANAB
Nasdaq
2836
www.anaptysbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AnaptysBio, Inc.
How AnaptysBio (ANAB) Stock Stands Out in a Strong Industry
- Jan 13th, 2025 2:42 pm
Big Biotech Fund Loads Up on a Stock That Surged in 2024, and a Loser
- Jan 12th, 2025 8:00 am
Are Medical Stocks Lagging United Therapeutics (UTHR) This Year?
- Jan 9th, 2025 2:40 pm
Anaptys to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Jan 7th, 2025 2:15 pm
AnaptysBio Stock Down as Eczema Study Fails to Meet Goals
- Dec 12th, 2024 2:04 pm
AnaptysBio’s atopic dermatitis trial of BTLA agonist misses endpoints
- Dec 12th, 2024 10:23 am
AnaptysBio Discontinues Investment In Eczema Candidate After Disappointing Data
- Dec 11th, 2024 7:07 pm
Top Midday Decliners
- Dec 11th, 2024 7:00 pm
Is Siga Technologies (SIGA) Stock Outpacing Its Medical Peers This Year?
- Dec 11th, 2024 2:40 pm
Anaptys Announces Phase 2b Trial of ANB032, a BTLA Agonist, Did Not Meet Primary or Secondary Endpoints in Atopic Dermatitis
- Dec 11th, 2024 1:30 pm
Are Medical Stocks Lagging AnaptysBio (ANAB) This Year?
- Nov 25th, 2024 2:40 pm
Broker Revenue Forecasts For AnaptysBio, Inc. (NASDAQ:ANAB) Are Surging Higher
- Nov 16th, 2024 1:15 pm
AnaptysBio (ANAB) Upgraded to Buy: What Does It Mean for the Stock?
- Nov 8th, 2024 5:00 pm
Down -32.84% in 4 Weeks, Here's Why You Should You Buy the Dip in AnaptysBio (ANAB)
- Nov 8th, 2024 2:35 pm
AnaptysBio Third Quarter 2024 Earnings: Beats Expectations
- Nov 7th, 2024 11:43 am
AnaptysBio, Inc. (ANAB) Reports Q3 Loss, Tops Revenue Estimates
- Nov 5th, 2024 10:30 pm
Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update
- Nov 5th, 2024 9:15 pm
Anaptys Announces Participation in November and December Investor Conferences
- Nov 5th, 2024 9:15 pm
Anaptys Announces Participation in September Investor Conferences
- Aug 29th, 2024 1:15 pm
Why AnaptysBio Was Such a Healthy Stock This Week
- Aug 23rd, 2024 11:26 am
Scroll